Abstract:INTRODUCTION: While oxidative stress can be measured during transient cerebral ischemia, antioxidant therapies for ischemic stroke have been clinically unsuccessful. Many antioxidants are limited in their range and/or capacity for quenching radicals and can generate toxic intermediates overwhelming depleted endogenous protection. We developed a new antioxidant class, 40 nm × 2 nm carbon nanoparticles, hydrophilic carbon clusters, conjugated to poly(ethylene glycol) termed PEG-HCCs. These particles are high-capacity superoxide dismutase mimics, are effective against hydroxyl radical, and restore the balance between nitric oxide and superoxide in the vasculature. Here, we report the effects of PEG-HCCs administered during reperfusion after transient middle cerebral artery occlusion (tMCAO) by suture in the rat under hyperglycemic conditions. Hyperglycemia occurs in one-third of stroke patients and worsens clinical outcome. In animal models, this worsening occurs largely by accelerating elaboration of reactive oxygen species (ROS) during reperfusion.METHODS: PEG-HCCs were studied for their protective ability against hydrogen peroxide in b.End3 brain endothelial cell line and E17 primary cortical neuron cultures. In vivo, hyperglycemia was induced by streptozotocin injection 2 days before tMCAO. 58 Male Sprague-Dawley rats were analyzed. They were injected IV with PBS or PEG-HCCs (4 mg/kg 2×) at the time of recanalization after either 90- or 120-min occlusion. Rats were survived for up to 3 days, and infarct volume characteristics and neurological functional outcome (modified Bederson Score) were assessed.RESULTS: PEG-HCCs were protective against hydrogen peroxide in both culture models. In vivo improvement was found after PEG-HCCs with 90-min ischemia with reduction in infarct size (42%), hemisphere swelling (46%), hemorrhage score (53%), and improvement in Bederson score (70%) (p = 0.068-0.001). Early high mortality in the 2-h in the PBS control group precluded detailed analysis, but a trend was found in improvement in all factors, e.g., reduction in infarct volume (48%; p = 0.034) and a 56% improvement in Bederson score (p = 0.055) with PEG-HCCs.CONCLUSION: This nano-antioxidant showed some improvement in several outcome measures in a severe model of tMCAO when administered at a clinically relevant time point. Long-term studies and additional models are required to assess potential for clinical use, especially for patients hyperglycemic at the time of their stroke, as these patients have the worst outcomes.

Antioxidant Effect of Ethyl Pyruvate in Respiring Neonatal Cerebrocortical Slices after H2O2 Stress

Evogenous Ethyl Pyruvate Versus Pyruvate During Metabolic Recovery After Oxidative Stress In Neonatal Rat Cerebroconical Slices

Pyruvate improves recovery after PARP-1-associated energy failure induced by oxidative stress in neonatal rat cerebrocortical slices.

Pyruvate administered to newborn rats with insulin-induced hypoglycemic brain injury reduces neuronal death and cognitive impairment

Ethyl Pyruvate Protects Against Hypoxic-Ischemic Brain Injury Via Anti-Cell Death and Anti-Inflammatory Mechanisms

Protective Effect of Ethyl Pyruvate on Brain Tissues in Neonatal Rats with Hypoxic-Ischemic Brain Damage

Mechanism of Protection of Ethyl Pyruvate against Oxidative Stress Injury in Hepatocytes

The Protective Effect Of Ganoderma Atrum Polysaccharide Against Anoxia/Reoxygenation Injury In Neonatal Rat Cardiomyocytes

Effects of Augmented Delivery of Pyruvate on Myocardial High-Energy Phosphate Metabolism at High Workstate

Reaction rate of pyruvate and hydrogen peroxide: assessing antioxidant capacity of pyruvate under biological conditions

Protective Effect of Polysaccharides from Ganoderma Atrum Against Oxidative Stress-induced Cardiomyocyte Injury in Neonatal Rats

Pyruvate improves cerebral metabolism during hemorrhagic shock

Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury By Inhibiting Intrinsic Pathway Of Apoptosis And Autophagy (Vol 2013, 461536, 2013)

Cardioprotection from Oxidative Stress in the Newborn Heart by Activation of PPARγ is Mediated by Catalase.

Ethyl Pyruvate Reduces Myocardial Ischemia and Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein in Rats

Delayed Treatment of NAD+ Can Restore Intracellular ATP Levels and Prevent PC12 Cell Death Induced by Oxidative Stress

Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through a glutathione-dependent mechanism

Efficacy of Novel Carbon Nanoparticle Antioxidant Therapy in a Severe Model of Reversible Middle Cerebral Artery Stroke in Acutely Hyperglycemic Rats

A Novel Therapeutic Approach With Sodium Pyruvate on Vital Signs, Acid–Base, and Metabolic Disturbances in Rats With a Combined Blast and Hemorrhagic Shock

Study of Preconditioning with Polygona-Polysaccharose Protects Cultured Neonatal Rat Myocardial Cells against Anoxia/Reoxygenation Injury

Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel.